Dermatology · Papulosquamous Disorders (Psoriasis, Lichen Planus)

In the management of erythrodermic psoriasis, which of the following systemic agents is CONTRAINDICATED due to risk of precipitating flare after withdrawal?

  • A Acitretin
  • B Systemic corticosteroids
  • C Cyclosporine
  • D Methotrexate
Correct answer: B. Systemic corticosteroids

Explanation

Systemic corticosteroids are contraindicated in psoriasis — particularly erythrodermic and pustular psoriasis — because rapid withdrawal after initial improvement triggers a severe rebound flare that can be life-threatening (conversion to pustular psoriasis). Acitretin (retinoid), cyclosporine, and methotrexate are the recommended systemic agents for erythrodermic psoriasis. Biologics (anti-TNF, anti-IL17, anti-IL23) are alternatives in refractory cases.

Reference: Neena Khanna Illustrated Synopsis of Dermatology & STD, 6th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Papulosquamous Disorders (Psoriasis, Lichen Planus) MCQs

See all Papulosquamous Disorders (Psoriasis, Lichen Planus) MCQs →